KMD Bioscience

Company profile

KMD Bioscience company profile

Since its establishment in 2014, KMD Bioscience (Tianjin) Co., Ltd. has been committed to becoming a leading provider of drug antibody discovery and related supporting services. We focus on technology research and development, providing high-quality CRO (Contract Research Organization) services to scientists and research institutions worldwide to promote the development and innovation of pharmaceutical technology. As a high-tech enterprise, we have obtained the national patent pilot unit and laboratory ISO9001:2015 quality management system certification, and have been awarded over 30 patents and 4 registered trademarks. Over 90% of KMD Bioscience's technical service team members hold master's degrees or above. Every year, we provide nearly a thousand technical service consultations, scheme designs, and project deliveries to various research institutions, hospitals, pharmaceutical companies, and biotech companies both domestically and internationally. Our core service platforms include an antibody drug discovery platform, antibody engineering modification platform, stable cell line construction and strain development process platform, recombinant antibody and recombinant protein expression and purification platform, etc.